Biolife Solutions (BLFS) Net Margin (2010 - 2025)

Biolife Solutions (BLFS) has 16 years of Net Margin data on file, last reported at 40.11% in Q4 2025.

• On a quarterly basis, Net Margin fell 3918.0% year-over-year to 40.11% in Q4 2025; TTM through Mar 2026 was 8.32%, a 559.0% increase from a year earlier, with the FY2025 full-year figure at 7.83%, up 2293.0% from the prior year.
• Net Margin for Q4 2025 stood at 40.11%, up from 62.3% in the prior quarter.
• Over the last five years, Net Margin for BLFS reached as high as 119.21% in Q4 2022 and fell as low as 179.8% in Q2 2022.
• Historically, Net Margin has averaged 17.17% across 5 years, with a median of 18.87% in 2023.
• Across the five-year window, Net Margin jumped 19036 bps in 2021 and sank 20504 bps in 2022, its largest moves.
• Year by year, Net Margin stood at 42.21% in 2021, then jumped by 382 bps to 119.21% in 2022, then slipped by 20 bps to 95.75% in 2023, then slipped by 17 bps to 79.3% in 2024, then slumped by 49 bps to 40.11% in 2025.
• Per Business Quant data, the three most recent Net Margin figures were 40.11% in Q4 2025, 62.3% in Q2 2025, and 2.03% in Q1 2025.